Open AccessAn expanding role for osimertinib for the treatment of ErbB family driven NSCLC
Author(s) -
Anthony C. Faber,
Timothy F. Burns
Publication year - 2018
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2018.08.10
Subject(s) - osimertinib , erbb , oncology , medicine , adenocarcinoma , cancer , ros1
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom